COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 1524: Articles 15231-15240  | Next

Variant-of-concern-attributable health and health system-related outcomes: a population-level propensity-score matched cohort study
Erman, A., Mishra, S., Barrett, K., Mac, S., Naimark, D. M., Sander, B.
10.1101/2021.06.02.21257869 — Posted: 2021-06-03
Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers
Scurr, M. J., Zelek, W. M., Lippiatt, G., Somerville, M. S., Burnell, S. E. A., Capitani, L., Davies, K., Lawton, H., Tozer, T., Rees, T., Roberts, K., Evans, M., Jackson, A., Young, C., Fairclough, L., Wills, M., Westwell, A. D., Morgan, B. P., Gallimore, A., Godkin, A.
10.1101/2021.06.02.21258218 — Posted: 2021-06-03
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: an observational cohort
Hall, M., ISARIC Clinical Characterisation Group
10.1101/2021.06.01.21258150 — Posted: 2021-06-03
Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
Barros-Martins, J., Hammerschmidt, S., Cossmann, A., Odak, I., Stankov, M. V., Morillas Ramos, G., Jablonka, A., Heidemann, A., Ritter, C., Friedrichsen, M., Schultze-Florey, C. R., Ravens, I., Stefanie, W., Bubke, A., Ristenpart, J., Janssen, A., Ssebyatika, G., Bernhardt, G., Muench, J. R., Hoffmann, M., Poehlmann, S., Krey, T., Bosnjak, B., Foerster, R., Behrens, G. M.
10.1101/2021.06.01.21258172 — Posted: 2021-06-03
Job stress and loneliness among remote workers
Miyake, F., Odgerel, C.-O., Hino, A., Ikegami, K., Nagata, T., Tateishi, S., Tsuji, M., Matsuda, S., Ishimaru, T.
10.1101/2021.05.31.21258062 — Posted: 2021-06-03
Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines
Thompson, M. G., Burgess, J. L., Naleway, A., Tyner, H., Yoon, S. K., Meece, J., Olsho, L. E. W., Caban-Martinez, A., Fowlkes, A. L., Lutrick, K., Groom, H. C., Dunnigan, K., Odean, M. J., Hegmann, K., Stefanski, E., Edwards, L. J., Schaefer-Solle, N., Grant, L., Ellingson, K., Kuntz, J. L., Zunie, T., Thiese, M. S., Ivacic, L., Wesley, M. G., Mayo Lamberte, J., Sun, X., Smith, M. E., Phillips, A. L., Groover, K. D., Yoo, Y. M., Gerald, J. K., Brown, R. T., Herring, M. K., Joseph, G., Beitel, S., Morrill, T. C., Mak, J., Rivers, P., Poe, B. P., Lynch, B., Tao Zhou, Y., Zhang, J., Kelleher, A., Li, Y., Dickerson, M. E., Hanson, E., Guenther, K., Tong, S., Bateman, A., Reisdorf, E., Barnes, J. R., Azziz-Baumgartner, E., Hunt, D. R., Arvay, M. L., Kutty, P., Fry, A. M., Gaglani, M.
10.1101/2021.06.01.21257987 — Posted: 2021-06-03 Discussion: Onsite
A Comparison of Four Commercially Available RNA Extraction Kits for Wastewater Surveillance of SARS-CoV-2 in a College Population
O'Brian, M., Rundell, Z. C., Nemec, M. D., Langan, L. M., Back, J. A., Lugo, J. N.
10.1101/2021.06.01.21257858 — Posted: 2021-06-03
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., VS, R., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Fatihi, S., Datta, M., Singh, P., Sharma, U., Ujjainia, R., Naushin, S., Batheja, N., Divakar, M. K., Sardana, V., Singh, M. K., Imran, M., Senthivel, V., Maurya, R., Jha, N., Mehta, P., Rophina, M., VR, A., Choudhary, U., Thukral, L., Pandey, R., Dash, D., Faruq, M., Lall, H., Gogia, H., Madan, P., Kulkarni, S., Chauhan, H., Sengupta, S., Kabra, S., The Indian SARS-CoV-2 Genomics Consortium (INSACOG), , Singh, S. K., Agrawal, A., Rakshit, P.
10.1101/2021.06.02.21258076 — Posted: 2021-06-03 Discussion: Onsite | Offsite
Analytical comparison of nine SARS-CoV-2 antigen-detecting rapid diagnostic tests for emerging SARS-CoV-2 variants
Bekliz, M., Adea, K., Essaidi, M., Sacks, J. A., Escadafal, C., Kaiser, L., Eckerle, I.
10.1101/2021.05.31.21258111 — Posted: 2021-06-03
Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike Protein after Natural Infection or COVID-19 vaccination
Sariol, C. A., Pantoja, P., Serrano-Collazo, C., Rosa-Arocho, T., Armina, A., Cruz, L., Stone, E. T., Arana, T., Climent, C., Latoni, G., Atheortua, D., Pabon-Carrero, C., Pinto, A. K., Brien, J. D., Espino, A. M.
10.1101/2021.06.02.21257975 — Posted: 2021-06-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).